Inter Pharma Public Company Limited
IP
Rank in Stocks
#20208
Based in Bangkok, Thailand, Inter Pharma Public Company Limited specializes in... Based in Bangkok, Thailand, Inter Pharma Public Company Limited specializes in the manufacturing, importing, and distribution of a wide array of health and dietary supplements designed for both human and animal use. The company's operations are divided into two primary segments: Human Healthcare and Animal Healthcare. Its Human Healthcare division provides a diverse range of items including medical supplies, nutritional therapy products, cosmetics, supplemental foodstuffs, probiotic and prebiotic offerings, health-focused and general food products, medical devices, and pharmaceutical medicines. This segment also extends to wellness and anti-aging solutions, aesthetic treatments like anti-wrinkle creams, hyaluronic fillers, and EGF cosmeceuticals, as well as diagnostic tools. For the Animal Healthcare sector, Inter Pharma caters to pets and livestock with veterinary provisions, nutritional support, vaccines, supplementary feeds, probiotic and prebiotic formulations, specialized animal health foods, premium and standard animal feeds, nutraceuticals, medicated shampoos, animal cosmeceuticals, and general pet and livestock food products. The company was founded in 2006 and is headquartered in Bangkok.
Share Price
$0.14672635
Last synced: 2026-11-10
Market Cap
$88.82M
Change (1 day)
0.82%
Change (1 year)
18.86%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Inter Pharma Public Company Limited (IP)
Category
Healthcare
Earnings for Inter Pharma Public Company Limited (IP)
Earnings in Jun 2026 TTM: $5.88M
According to Inter Pharma Public Company Limited's latest financial reports, its current earnings (TTM) are $5.88M. In 2025 the company earned $5.44M, an increase over its 2024 earnings of $1.58M. The earnings shown on this page are earnings before interest and taxes, or EBIT.
Earnings history for Inter Pharma Public Company Limited from 2016 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $5.88M | 8.21% |
| 2025 | $5.44M | 243.28% |
| 2024 | $1.58M | -32.99% |
| 2023 | $2.36M | -44.64% |
| 2022 | $4.27M | 2.91% |
| 2021 | $4.15M | 61.12% |
| 2020 | $2.57M | 25.39% |
| 2019 | $2.05M | 64.38% |
| 2018 | $1.25M | 43.32% |
| 2017 | $871.46K | 37.32% |
| 2016 | $634.63K | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $4.76B | 80,814.23% |
US
|
|
| $-2.73B | -46,494.56% |
US
|
|
| $-4.02B | -68,377.64% |
AU
|
|
| $2.83B | 47,940.61% |
BE
|
|
| $1.50B | 25,348.87% |
NL
|
Questions about Inter Pharma Public Company Limited's net income
What is Inter Pharma Public Company Limited's net income?
Inter Pharma Public Company Limited's net income over the last twelve months is $5.88M, as of Jun 2026.
What was Inter Pharma Public Company Limited's net income in 2025?
In 2025, Inter Pharma Public Company Limited's net income was $5.44M, 243.28% more than in 2024 ($1.58M).
How has Inter Pharma Public Company Limited's net income changed since 2020?
From 2020 to 2025, Inter Pharma Public Company Limited's net income went from $2.57M to $5.44M, an average growth of 16.12% a year.
How does Inter Pharma Public Company Limited's net income compare with similar companies?
Inter Pharma Public Company Limited's net income ($5.88M) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $4.76B.